articles

The prognosis for multiple myeloma depends on the stage of the disease at diagnosis using the international staging system; median survival is 62 months for stage 1 multiple myeloma, according to the American Cancer Soci... More »

www.reference.com Health Conditions & Diseases Cancer

According to the Mayo Clinic, multiple myeloma is a cancer that develops in plasma cells. Plasma cells are white blood cells that help the body fight infections by producing antibodies to detect and attack germs. More »

www.reference.com Health Conditions & Diseases Cancer

End stage multiple myeloma is the final stage of advanced multiple myeloma. According to MedlinePlus, the symptoms of end stage multiple myeloma include vomiting, nausea, urination problems, numbness in legs and constipa... More »

www.reference.com Health Conditions & Diseases Cancer
similar articles

The life expectancy for someone with multiple myeloma depends on the stage of the disease when diagnosed, according to the American Cancer Society. Stage I patients have a median survival rate of 62 months. Stage II pati... More »

www.reference.com Health Conditions & Diseases Cancer

The prognosis for stage 3 renal cell, or kidney, cancer is a 53 percent survival rate five years after diagnosis, according to the American Cancer Society. Many factors affect the survival rate, including other health co... More »

www.reference.com Health Conditions & Diseases Cancer

Oncolytic virotherapy used on patients with stage 4 multiple myeloma suggest that, at least for some patients, it is possible to survive stage 4 or “end-stage” multiple myeloma. Mayo Clinic researchers using laboratory-e... More »

www.reference.com Health Conditions & Diseases Cancer

The survival rates for multiple myeloma are 62, 44 and 29 months for stages one, two and three, respectively, according to Cancer.org. Physicians use survival rates for multiple myeloma, a type of cancer that affects pla... More »

www.reference.com Health Conditions & Diseases Cancer